Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-24 @ 11:44 PM
NCT ID:
NCT00002851
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed unilateral adenocarcinoma of the breast
* Stage I/II/III (Tx, T0-3, N0-2) disease in one of the following categories or multifocal tumors if one of the foci is in agreement with the following:
* Centrally or medially located with any lymph node status
* Central location defined as underlying the areola
* Medial location defined as at least partial involvement of upper or lower medial quadrant of breast
* Externally located with axillary node involvement
* Prior mastectomy or breast-conserving surgery and axillary dissection required
* Sentinel node procedure as axillary intervention without further axillary surgery is allowed
* No prior internal mammary chain dissection
* No upper inner lesion treated with breast-conserving surgery that precludes sparing of internal mammary lymph node chain from radiotherapy volume
* Decision at radiation oncologist's discretion
* Hormone receptor status:
* Not specified
PATIENT CHARACTERISTICS:
Age:
* 75 and under
Sex:
* Female
Menopausal status:
* Not specified
Performance status:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Cardiovascular:
* No prior cardiac disease
Other:
* No prior malignancy except adequately treated nonmelanomatous skin cancer or carcinoma in situ of the cervix
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* Not specified
Endocrine therapy:
* Not specified
Radiotherapy:
* Not specified
Surgery:
* See Disease Characteristics
Other:
* Concurrent enrollment in other randomized trials allowed
Healthy Volunteers:
False
Sex:
FEMALE
Maximum Age:
75 Years
Study:
NCT00002851
Study Brief:
Protocol Section:
NCT00002851